Limited sampling strategy for predicting isoniazid exposure in patients with extrapulmonary tuberculosis-Reference-Cited by-同舟云学术

Limited sampling strategy for predicting isoniazid exposure in patients with extrapulmonary tuberculosis

Published:2019-12-13 Issue:3 Volume:45 Page:503-512
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Alshaikheid Mohammed¹^ORCID,Chaabane Amel¹,Ben Fredj Nadia¹,Ben Brahim Hajer²,Ben Fadhel Najah¹,Chadli Zohra¹,Slama Ahlem¹,Boughattas Naceur A.¹,Chakroun Mohamed²,Aouam Karim¹

Affiliation:

1. Laboratory of Pharmacology Faculty of Medicine of Monastir Monastir Tunisia

2. Department of Infectious Diseases University Hospital of Monastir Monastir Tunisia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13098

Reference32 articles.

1. The Chemical Approach to the Control of Tuberculosis

2. The challenges of pharmacokinetic variability of first-line anti-TB drugs

3. Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients

4. The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid

5. La pharmacocinétique de l'isoniazide dans la race blanche;Vivien J;Rev Fr Mal Respir,1973

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis;European Journal of Drug Metabolism and Pharmacokinetics;2024-08-17

2. Model‐based precision dosing and remedial dosing recommendations for delayed or missed doses of isoniazid in Chinese patients with tuberculosis;British Journal of Clinical Pharmacology;2024-04-03

3. Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review;Clinical and Translational Science;2024-04

4. Limited sampling strategies for therapeutic drug monitoring of anti-tuberculosis medications: A systematic review of their feasibility and clinical utility;Tuberculosis;2023-07

5. Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population;Frontiers in Pharmacology;2022-07-19